Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Assets: 2020-2024

Historic Assets for Caribou Biosciences (CRBU) over the last 5 years, with Dec 2024 value amounting to $313.3 million.

  • Caribou Biosciences' Assets fell 43.37% to $195.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $195.0 million, marking a year-over-year decrease of 43.37%. This contributed to the annual value of $313.3 million for FY2024, which is 27.51% down from last year.
  • Latest data reveals that Caribou Biosciences reported Assets of $313.3 million as of FY2024, which was down 27.51% from $432.2 million recorded in FY2023.
  • Caribou Biosciences' 5-year Assets high stood at $442.4 million for FY2021, and its period low was $36.0 million during FY2020.
  • For the 3-year period, Caribou Biosciences' Assets averaged around $373.1 million, with its median value being $373.8 million (2022).
  • Per our database at Business Quant, Caribou Biosciences' Assets skyrocketed by 1,127.20% in 2021 and then declined by 27.51% in 2024.
  • Over the past 5 years, Caribou Biosciences' Assets (Yearly) stood at $36.0 million in 2020, then skyrocketed by 1,127.20% to $442.4 million in 2021, then decreased by 15.51% to $373.8 million in 2022, then increased by 15.64% to $432.2 million in 2023, then fell by 27.51% to $313.3 million in 2024.